Simvastatin has been shown to regulate the expression of phosphorylated forms of ERK1\2 (extracellular-signal-regulated kinases) and the expression of cell cycle regulators, such as p21 and p27, in HNSCC cells [132, 134]. Here, MAPK3 is linked to head and neck squamous cell carcinoma.